Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma

Abstract Background The role of transarterial chemoembolization (TACE) as the standard treatment for intermediate‐stage hepatocellular carcinoma (HCC) is being challenged by increasing studies supporting liver resection (LR); but evidence of survival benefits of LR is lacking. We aimed to compare th...

Full description

Bibliographic Details
Main Authors: Shuling Chen, Huilin Jin, Zihao Dai, Mengchao Wei, Han Xiao, Tianhong Su, Bin Li, Xin Liu, Yu Wang, Jiaping Li, Shunli Shen, Qi Zhou, Baogang Peng, Zhenwei Peng, Sui Peng
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Cancer Medicine
Subjects:
intermediate‐stage hepatocellular carcinoma
liver resection
Markov Model
propensity score matching
transarterial chemoembolization
Online Access:https://doi.org/10.1002/cam4.2038

Internet

https://doi.org/10.1002/cam4.2038

Similar Items